Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.58 EUR | +0.99% |
|
+3.36% | +8.95% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 7.26 and 6.62 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Historically, the company has been releasing figures that are above expectations.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.95% | 4.75B | - | ||
+20.76% | 43.77B | B- | ||
+28.00% | 22.83B | B+ | ||
+20.25% | 15.56B | - | ||
+18.82% | 14.34B | B+ | ||
+55.83% | 12.96B | B | ||
-0.05% | 6.79B | - | - | |
-12.70% | 6.41B | B+ | ||
-8.87% | 5.73B | - | - | |
+14.65% | 5.69B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RICHTER Stock
- RIG2 Stock
- Ratings Gedeon Richter